Arcoma AB has cancelled its previously scheduled extra general meeting for November 25, 2026. The board has called a new meeting for December 9, 2026, to ensure the proposed share buyback authorization aligns with new Swedish Companies Act rules for Nasdaq First North companies, which take effect on December 5, 2026.
The board is postponing the extra general meeting from 25 November to 9 December 2026 so the buyback authorization can be decided after the new Swedish Companies Act rules for Nasdaq First North buybacks take effect on 5 December 2026. The proposal itself is unchanged and will still be voted on, so the substance is intact; only the timing is pushed back by two weeks. A procedural reschedule without figures or changed guidance is routine and unlikely to move the price materially.
- • New extra general meeting on 9 December 2026 to vote on the buyback authorization
- • New companies act rules enabling share buybacks effective 5 December 2026
- • Further two-week delay in securing shareholder authorization for share repurchases